Substituted 1H-benzimidazole-4-carboxamides are potent PARP inhibitors
申请人:Abbott Laboratories
公开号:US07462724B2
公开(公告)日:2008-12-09
Compounds of Formula (I)
inhibit the PARP enzyme and are useful for treating a disease or a disorder associated with PARP. Also disclosed are pharmaceutical compositions comprising compounds of Formula (I), methods of treatment comprising compounds of Formula (I), and methods of inhibiting the PARP enzyme comprising compounds of Formula (I).